Moleculin Biotech, Inc. Increase (Decrease) in Interest Payable, Net
Moleculin Biotech, Inc. (MBRX) reported Increase (Decrease) in Interest Payable, Net of -$30.00 thousand for the 13-month period ending 2017-06-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2017-11-13
- 2017-06-30: Increase (Decrease) in Interest Payable, Net 13 month -$30.00K.
- 2016-05-31: Increase (Decrease) in Interest Payable, Net -$20.00K.
| Period end | Increase (Decrease) in Interest Payable, Net | Increase (Decrease) in Interest Payable, Net 13 month |
|---|---|---|
| 2017-06-30 | -$30.00K 10-Q · filed 2017-11-13 | |
| 2016-05-31 | -$20.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |